JP2008521796A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008521796A5 JP2008521796A5 JP2007542516A JP2007542516A JP2008521796A5 JP 2008521796 A5 JP2008521796 A5 JP 2008521796A5 JP 2007542516 A JP2007542516 A JP 2007542516A JP 2007542516 A JP2007542516 A JP 2007542516A JP 2008521796 A5 JP2008521796 A5 JP 2008521796A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- disease
- stem cells
- pharmaceutical composition
- neuropathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63116304P | 2004-11-29 | 2004-11-29 | |
| US60/631,163 | 2004-11-29 | ||
| US69049805P | 2005-06-15 | 2005-06-15 | |
| US60/690,498 | 2005-06-15 | ||
| PCT/IL2005/001275 WO2006057003A2 (en) | 2004-11-29 | 2005-11-29 | Induction of neurogenesis and stem cell therapy in combination with copolymer 1 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012248619A Division JP2013040204A (ja) | 2004-11-29 | 2012-11-12 | コポリマー１と組み合わせた、神経発生の誘発及び幹細胞治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008521796A JP2008521796A (ja) | 2008-06-26 |
| JP2008521796A5 true JP2008521796A5 (enExample) | 2009-01-22 |
| JP5294635B2 JP5294635B2 (ja) | 2013-09-18 |
Family
ID=36498362
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007542516A Expired - Fee Related JP5294635B2 (ja) | 2004-11-29 | 2005-11-29 | コポリマー１と組み合わせた、神経発生の誘発及び幹細胞治療 |
| JP2012248619A Abandoned JP2013040204A (ja) | 2004-11-29 | 2012-11-12 | コポリマー１と組み合わせた、神経発生の誘発及び幹細胞治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012248619A Abandoned JP2013040204A (ja) | 2004-11-29 | 2012-11-12 | コポリマー１と組み合わせた、神経発生の誘発及び幹細胞治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20090191173A1 (enExample) |
| EP (1) | EP1827108B1 (enExample) |
| JP (2) | JP5294635B2 (enExample) |
| AU (1) | AU2005308396B2 (enExample) |
| CA (1) | CA2588908C (enExample) |
| ES (1) | ES2541780T3 (enExample) |
| WO (1) | WO2006057003A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
| WO2009040814A1 (en) * | 2007-09-24 | 2009-04-02 | Hadasit Medical Research Services & Development Ltd | Use of copolymer 1 for treatment of muscular dystrophy |
| WO2010071862A1 (en) * | 2008-12-19 | 2010-06-24 | Ethicon, Incorporated | Umbilical cord tissue derived cells for treating neuropathic pain and spasticity |
| PL2411504T3 (pl) | 2009-03-26 | 2017-10-31 | Depuy Synthes Products Inc | Komórki ludzkiej tkanki pępowinowej jako terapia choroby Alzheimera |
| AU2010289419A1 (en) * | 2009-09-02 | 2012-03-29 | The University Of Chicago | Methods and systems for inducible ablation of neural cells |
| USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| ES2601892T3 (es) | 2011-04-21 | 2017-02-16 | Mapi Pharma Limited | Pentapolímero aleatorio para el tratamiento de enfermedades autoinmunes |
| GB201300684D0 (en) | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
| EP3478300B1 (en) | 2016-06-30 | 2022-08-24 | Stem Cell Medicine Ltd. | Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells |
| CN107703292B (zh) * | 2016-08-09 | 2019-07-12 | 杨琴 | BrdU标记免疫荧光检测细胞增殖的改良方法 |
| US12097292B2 (en) | 2016-08-28 | 2024-09-24 | Mapi Pharma Ltd. | Process for preparing microparticles containing glatiramer acetate |
| AU2017319728B2 (en) | 2016-08-31 | 2024-09-05 | Mapi Pharma Ltd | Depot systems comprising glatiramer acetate |
| IL316573A (en) | 2017-03-26 | 2024-12-01 | Mapi Pharma Ltd | Storage systems containing glatiramer acetate for the treatment of multiple sclerosis |
| IL269893B2 (en) | 2017-05-15 | 2023-10-01 | Stem Cell Medicine Ltd | Treatment of multiple sclerosis with adipose-derived stem cells |
| EP3624815A4 (en) * | 2017-05-15 | 2021-01-20 | Stem Cell Medicine Ltd. | TREATMENT OF MULTIPLE SCLEROSIS WITH LONG-ACTING GLATIRAMER AND ADAPTIVE STEM CELLS |
| EP3765034A1 (en) | 2018-03-12 | 2021-01-20 | Yeda Research and Development Co. Ltd | Treatment of a heart disease |
| KR101994640B1 (ko) * | 2018-03-16 | 2019-07-02 | (주)메디노 | 신경줄기세포의 고효율 분리배양 방법 |
| WO2020245832A1 (en) * | 2019-06-07 | 2020-12-10 | Ramot At Tel-Aviv University Ltd. | Compositions and methods of using same for tissue regeneration |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5980885A (en) * | 1991-07-08 | 1999-11-09 | Neurospheres Holdings Ltd. | Growth factor-induced proliferation of neural precursor cells in vivo |
| US6497872B1 (en) * | 1991-07-08 | 2002-12-24 | Neurospheres Holdings Ltd. | Neural transplantation using proliferated multipotent neural stem cells and their progeny |
| US6294346B1 (en) * | 1991-07-08 | 2001-09-25 | Neurospheres Holdings, Ltd. | Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents |
| US6071889A (en) * | 1991-07-08 | 2000-06-06 | Neurospheres Holdings Ltd. | In vivo genetic modification of growth factor-responsive neural precursor cells |
| IL113812A (en) * | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
| IL112834A (en) * | 1995-03-01 | 2000-12-06 | Yeda Res & Dev | Pharmaceutical compositions for controlled release of soluble receptors |
| US6214791B1 (en) * | 1997-01-10 | 2001-04-10 | Yeda Research And Development Co. Ltd. | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| JP2002503658A (ja) * | 1998-02-13 | 2002-02-05 | オートイミューン インク | ＣＯＰ−１及びＴｈ−２促進性サイトカインを使用した、多発性硬化症の治療 |
| SE9802264D0 (sv) * | 1998-06-25 | 1998-06-25 | Neuronova Ab | A method of isolating cells |
| ES2527760T3 (es) * | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos |
| US6800287B2 (en) * | 1998-09-25 | 2004-10-05 | Yeda Research And Development Co., Ltd. | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| US6531130B1 (en) * | 1999-07-06 | 2003-03-11 | The Board Of Trustees Of The Leland Stanford University | Treatment of demyelinating autoimmune disease with ordered peptides |
| HK1054507B (zh) * | 2000-01-20 | 2008-10-31 | 耶达研究及发展有限公司 | 共聚物1和相关肽和多肽及其处理过的t细胞在神经保护性治疗中的用途 |
| US7037493B2 (en) * | 2000-05-01 | 2006-05-02 | Cornell Research Foundation, Inc. | Method of inducing neuronal production in the brain and spinal cord |
| US20020077278A1 (en) * | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| DE60116467T2 (de) * | 2000-06-07 | 2006-11-02 | Yeda Research And Development Co., Ltd. | Verwendung des Copolymer-1 Peptids sowie von damit verwandten Peptiden und Polypeptiden und von damit behandelten T-Zellen zur Neuroprotektion gegen die Toxizität von Glutamat |
| US6835711B2 (en) * | 2001-06-28 | 2004-12-28 | Yeda Research And Development Co. Ltd. | Use of poly-Glu,Tyr for neuroprotective therapy |
| US7399740B2 (en) * | 2001-06-28 | 2008-07-15 | Yeda Research And Development Co. Ltd. | Poly-Glu,Tyr for neuroprotective therapy |
| EP1459065B1 (en) * | 2001-12-04 | 2010-07-28 | Teva Pharmaceutical Industries, Ltd. | Processes for the measurement of the potency of glatiramer acetate |
| JP4374469B2 (ja) * | 2002-01-09 | 2009-12-02 | 独立行政法人科学技術振興機構 | 記憶障害治療剤 |
| US7576065B2 (en) * | 2002-02-15 | 2009-08-18 | Cornell Research Foundation, Inc. | Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein |
| WO2005032482A2 (en) * | 2003-10-03 | 2005-04-14 | Bayhill Therapeutics, Inc. | Treatment of demyelinating autoimmune disease with modified ordered peptides |
-
2005
- 2005-11-29 ES ES05810540.4T patent/ES2541780T3/es not_active Expired - Lifetime
- 2005-11-29 JP JP2007542516A patent/JP5294635B2/ja not_active Expired - Fee Related
- 2005-11-29 AU AU2005308396A patent/AU2005308396B2/en not_active Ceased
- 2005-11-29 CA CA2588908A patent/CA2588908C/en not_active Expired - Lifetime
- 2005-11-29 EP EP05810540.4A patent/EP1827108B1/en not_active Expired - Lifetime
- 2005-11-29 US US11/791,681 patent/US20090191173A1/en not_active Abandoned
- 2005-11-29 WO PCT/IL2005/001275 patent/WO2006057003A2/en not_active Ceased
-
2011
- 2011-10-26 US US13/281,908 patent/US20120135016A1/en not_active Abandoned
-
2012
- 2012-11-12 JP JP2012248619A patent/JP2013040204A/ja not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mohammadi et al. | Dysfunction in brain-derived neurotrophic factor signaling pathway and susceptibility to schizophrenia, Parkinson's and Alzheimer's diseases | |
| Choi et al. | M2 phenotype microglia-derived cytokine stimulates proliferation and neuronal differentiation of endogenous stem cells in ischemic brain | |
| Corrigan et al. | The neuroprotective domains of the amyloid precursor protein, in traumatic brain injury, are located in the two growth factor domains | |
| ES2569881T3 (es) | Procedimientos para facilitar la supervivencia de células neuronales usando miméticos de neurotrofina BDNF peptídicos y no peptídicos | |
| Zhou et al. | Pentraxin 3 contributes to neurogenesis after traumatic brain injury in mice | |
| ES2882881T3 (es) | Uso de moléculas de unión a semaforina-4D para promover la neurogénesis tras un ictus | |
| KR20100063719A (ko) | Ｎａｐ 유사 및 ｓａｌ 유사 펩티드 모의체를 사용한 신경보호 | |
| Flohr | Post-lesion neural plasticity | |
| ES2656353T3 (es) | Nuevas aplicaciones de HIP/PAP o derivados de la misma | |
| CN103648517A (zh) | 神经保护肽 | |
| Yu et al. | Synergistic and superimposed effect of bone marrow-derived mesenchymal stem cells combined with fasudil in experimental autoimmune encephalomyelitis | |
| Yadav et al. | The development of treatment for Parkinson’s disease | |
| JP4685354B2 (ja) | 神経細胞の再生におけるｉｌ６ｒ／ｉｌ６キメラの使用 | |
| ES2353490T3 (es) | Factores de estimulación de la supervivencia neuronal dopaminérgica y sus utilizaciones. | |
| DE60035192T2 (de) | Tgf-alpha polypeptide, funktionelle fragmente und verfahren zu ihrer anwendung | |
| ES2827923T3 (es) | Composiciones y métodos de tratamiento durante los períodos no agudos después de una lesión neurológica del CNS | |
| JP2015147764A5 (enExample) | ||
| Huang et al. | Clinical neurorestorative progress in traumatic brain injury | |
| JP2007511210A5 (enExample) | ||
| KR102414649B1 (ko) | 에리스로포이에틴-유래된 펩타이드, 이의 제조 방법 및 이의 용도 | |
| ES2444569T3 (es) | Quimera IL-6R/IL-6 para terapia de neuropatía periférica inducida por quimioterapia | |
| Liao | Therapeutic Application of Perinatal Mesenchymal Stem Cells in Nervous System Diseases | |
| Kułak et al. | Cell therapy: a new hope for treatment of cerebral palsy? | |
| WO2023072069A1 (zh) | 异野漆树苷及其衍生物用于促进神经修复的用途 | |
| Hashemi | Isolation of cancer stem cells and astrocytes from human glioblastoma: morphological characterization of two cells types |